Why Tempus AI Stock Soared 15.2% in June

The market's appetite for artificial intelligence (AI) stocks remains unyielding, and it doesn't seem poised to wane anytime soon

In addition to a perspective on the critical report written the company that's AI solutions for healthcare applications, analysts' auspicious opinions on Tempus AI stock and the company's development vided motivation for investors

Image source: Getty Images

The critical report -- TD says there's nothing to see here; move along ing the release of a critical report by Spruce Point Capital Management Tempus AI in May, investors rushed to exit their positions

But the selling activity reversed course in early June when investors learned that TD Cowen was unmoved by the report

Com, TD Cowen's analyst found "some of [the] stated concerns misleading or incorrect. "Another catalyst for the stock's rise last month came from the company's introduction of its Fuses gram

An initiative to vide even greater individualized care for patients, the Fuses gram will grow the company's AI-assisted diagnostics and expand its comprehensive testing portfolio, using machine learning coupled with data from its expansive library

Bullish sentiment from Wall Street helped Tempus AI stock sustain the gains it had logged throughout the month

Is now a good time to buy Tempus AI stock

With s of Tempus AI climbing steadily over the past several months, it's reasonable for spective investors to question whether they've missed the boat

At this point, though, it seems that this is hardly the case

Tempus AI is early in its development, and the use of AI to vide individualized healthcare is a nascent industry that will ly boom in the coming years

Naturally, Tempus AI stock will face some volatility as the company strives to overcome the hurdles that face growth companies

Those with long horizons, however, would be well advised to give the stock a serious look, as there certainly remains plenty of potential for the stock to soar even higher

Bank of America is an advertising partner of Motley Fool Money

Scott Levine has no position in any of the stocks mentioned

The Motley Fool has positions in and recommends Bank of America

The Motley Fool has a disclosure policy.